Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

PennyMac Mortgage Investment Trust (PMT), Two Harbors Investment Corp (TWO): Why This Mortgage REIT Can Do What No Others Dare

After a brutal earnings season during which most mortgage REITs reported second-quarter declines in book value, PennyMac Mortgage Investment Trust (NYSE:PMT) swam against the tide. In addition to beating revenue estimates, the company reported an actual gain in book value from the previous quarter, of 1.6%. With that victory under its belt, the company is embarking on a secondary offering of 11.3 million shares, with an option for its underwriters of almost 1.7 million additional shares.

Diversification was key
How did PennyMac Mortgage Investment Trust (NYSE:PMT) achieve such a triumph in the current climate? Much like Two Harbors Investment Corp (NYSE:TWO), which reported lower book value damage than most of its peers, PennyMac Mortgage Investment Trust (NYSE:PMT) owes its success to a varied business stream — particularly its correspondent lending business, which contributed revenues that increased by 42% from the first quarter.

Mortgage servicing income was robust in the second quarter, as well. Fees jumped from $6.6 million in the first quarter to $7.9 million, and PennyMac Mortgage Investment Trust (NYSE:PMT) notes that mortgage servicing rights are positioned well for the rising interest rate environment because of a drop in prepayments.

One of PennyMac Mortgage Investment Trust (NYSE:PMT)’s specialties is the acquisition of pools of distressed loans. The company purchases these assets at a discount, then either liquidates them, or returns these mortgages to profitability through loan modifications. Troubled loans engender higher servicing fees, as well — another feather in PennyMac Mortgage Investment Trust (NYSE:PMT)’s lucrative cap.

The jumbo-loan business is taking off
PennyMac Mortgage Investment Trust (NYSE:PMT), like Two Harbors, is moving into the jumbo market, including securitization activity. During Q2, the trust agreed to buy $393 million of prime jumbo loans, which it plans to blend with jumbos it purchases through its correspondence channel — which it will securitize and sell sometime during the third quarter.

PennyMac Mortgage Investment Trust (NYSE:PMT) considers jumbo securitization a profitable opportunity for the company, and it seems to be catching on with mREITs. Two Harbors participated in a prime jumbo securitization earlier this year and has plans to do so again very soon.

Annaly Capital Management, Inc. (NYSE:NLY)Even Annaly Capital Management, Inc. (NYSE:NLY), which was a pristine agency-only player for so many years, has recently revealed an interest in securitization and jumbo loans — though, at least for now, as separate activities. With its recent acquisition of CreXus, Annaly Capital Management, Inc. (NYSE:NLY) and CEO Wellington Denahan acknowledged plans to securitize some of its corporate debt, and the company noted that, sometime in the future, it will likely be originating jumbo loans through one of its affiliates, Shannon Funding.

Flexibility will protect yields
PennyMac Mortgage Investment Trust (NYSE:PMT) proves that variety is the stuff of profits, and it looks like other mortgage REITs are finding the same to be true. As the unstable economic environment continues to rock the sector, it seems obvious that the mREITs that are willing to change and adjust will deliver the best value to their investors.

Fool contributor Amanda Alix has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!